Schizophrenia Trial, Recruiting NCT06005766 Sponsor: University of Jyvaskyla Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06005766
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • You are willing to take part in a scientific study
  • You have been diagnosed with a psychosis spectrum disorder
  • You can read and understand Finnish, as the questionnaires and tests are in Finnish

For people joining as healthy comparison participants (non-patients):

  • You are willing to take part in a scientific study
  • You feel you have a good enough level of Finnish to complete questionnaires and tests in that language

Who may not be able to join:

For patients:

  • Your psychosis severely affects your ability to carry out day-to-day activities
  • You have cognitive (thinking or memory) difficulties that severely affect your ability to carry out day-to-day activities
  • You have a legal guardian appointed to make personal decisions on your behalf

For people joining as healthy comparison participants (non-patients):

  • You have been diagnosed with a psychosis spectrum disorder
  • You have cognitive (thinking or memory) difficulties that severely affect your ability to carry out day-to-day activities

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Raimo Lappalainen, PhD, University of Jyvaskyla

Phone: 029 524 3058

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Jyvaskyla
Registry
ClinicalTrials.gov
Start date
1 September 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Jumping to conclusions bias

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov